Tecovirimat SIGA
What Tecovirimat SIGA is used for
Tecovirimat SIGA is indicated for the treatment of the following viral infections in adults and children with body weight at least 13kg: Smallpox Cowpox Tecovirimat SIGA is also indicated to treat complications due to replication of vaccinia virus following vaccination against smallpox in adults and children with body weight at least 13kg . Tecovirimat SIGA should be used in accordance with official recommendations.
Approved use, as published by the European Medicines Agency.
What the labels mean
- Approved under exceptional circumstances: full data cannot be collected, usually because the disease is very rare.
Key facts
- Brand
- Tecovirimat SIGA
- Active substance
- tecovirimat monohydrate
- Disease area
- Poxviridae Infections; Cowpox; Monkeypox; Vaccinia; Smallpox
- Medicine group
- Antivirals for systemic use
- ATC code
- J05AX24
- Marketing authorisation holder
- SIGA Technologies Netherlands B.V.
- Authorised in the EU since
- 2022
Official information
Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.
Common questions
What is Tecovirimat SIGA used for?
Tecovirimat SIGA is indicated for the treatment of the following viral infections in adults and children with body weight at least 13kg: Smallpox Cowpox Tecovirimat SIGA is also indicated to treat complications due to replication of vaccinia virus following vaccination against smallpox in adults and children with body weight at least 13kg . Tecovirimat SIGA should be used in accordance with official recommendations.
What is the active substance in Tecovirimat SIGA?
Tecovirimat SIGA contains tecovirimat monohydrate.
Who makes Tecovirimat SIGA?
The EU marketing authorisation holder is SIGA Technologies Netherlands B.V..
Source: European Medicines Agency medicines data (ema.europa.eu), reproduced with acknowledgement of the source. Page made 5 November 2026 by Satya Babu.
← All specialty medicines, EU